Physical mixtures were prepared containing indomethacin and beta-lactose and alpha-lactose-based excipients (Ludipress and Cellactose). The mixtures were compacted with the aid of ultrasound, obtaining tablets, which were milled and sieved. Granules thus obtained were examined by optical microscopy and differential scanning calorimetry. The intense yellow color of the granules and the absence of indomethacin peak in thermograms suggest important modifications of indomethacin physical state; the drug thus modified appears to be spread on the excipient particle surface as a thin film, giving a lustrous appearance. No influence of ultrasound was observed on phase transition concerning lactose; only loss of water was important under high energy ultrasound. Dissolution profiles suggest an increased release of the drug from the systems treated with ultrasound at high energy, with respect to a traditional compaction; while no difference could be evidenced among the three excipients that, however, appear all suitable for this ultrasound-aided direct compression process.

Cavallari, C., Albertini, B., Rodriguez, L., Rabasco, A.M., Fini, A. (2005). Release of indomethacin from ultrasound dry granules containing lactose-based excipients. JOURNAL OF CONTROLLED RELEASE, 102 (1), 39-47 [10.1016/j.jconrel.2004.09.017].

Release of indomethacin from ultrasound dry granules containing lactose-based excipients

CAVALLARI, CRISTINA;ALBERTINI, BEATRICE;RODRIGUEZ, LORENZO;FINI, ADAMO
2005

Abstract

Physical mixtures were prepared containing indomethacin and beta-lactose and alpha-lactose-based excipients (Ludipress and Cellactose). The mixtures were compacted with the aid of ultrasound, obtaining tablets, which were milled and sieved. Granules thus obtained were examined by optical microscopy and differential scanning calorimetry. The intense yellow color of the granules and the absence of indomethacin peak in thermograms suggest important modifications of indomethacin physical state; the drug thus modified appears to be spread on the excipient particle surface as a thin film, giving a lustrous appearance. No influence of ultrasound was observed on phase transition concerning lactose; only loss of water was important under high energy ultrasound. Dissolution profiles suggest an increased release of the drug from the systems treated with ultrasound at high energy, with respect to a traditional compaction; while no difference could be evidenced among the three excipients that, however, appear all suitable for this ultrasound-aided direct compression process.
2005
Cavallari, C., Albertini, B., Rodriguez, L., Rabasco, A.M., Fini, A. (2005). Release of indomethacin from ultrasound dry granules containing lactose-based excipients. JOURNAL OF CONTROLLED RELEASE, 102 (1), 39-47 [10.1016/j.jconrel.2004.09.017].
Cavallari, Cristina; Albertini, Beatrice; Rodriguez, Lorenzo; Rabasco, A. M.; Fini, Adamo
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/2358
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact